Advertisement
Screener

PAVmed Inc. (PAVM) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

PAVmed Inc. Net Income (Loss) Available to Common Stockholders, Basic

PAVmed Inc. (PAVM) reported Net Income (Loss) Available to Common Stockholders, Basic of -$5.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-13

  • PAVmed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$5.48M.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$6.99M, a 139.49% decline year-over-year.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$1.83M, a 236.11% decline year-over-year.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$6.33M, a 109.84% decline year-over-year.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$3.77M, a 111.81% decline from fiscal 2024.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was $31.97M.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$66.27M.
  • PAVmed Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$89.26M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2026-06-30-$5.48M
10-Q · filed 2026-08-13
-$12.47M
10-Q · filed 2026-08-13
-$14.30M
derived: sum of 3 quarters · filed 2026-08-13
-$20.63M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$6.99M
10-Q · filed 2026-05-14
-$8.82M
derived: sum of 2 quarters · filed 2026-05-14
-$15.15M
derived: sum of 3 quarters · filed 2026-05-14
-$28.46M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$8.16M
derived: sum of 2 quarters · filed 2026-03-27
-$21.47M
derived: sum of 3 quarters · filed 2026-08-13
-$3.77M
10-K · filed 2026-03-27
2025-09-30-$6.33M
10-Q · filed 2025-11-12
-$19.64M
derived: sum of 2 quarters · filed 2026-08-13
-$1.94M
10-Q · filed 2025-11-12
-$595.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$13.31M
10-Q · filed 2026-08-13
$4.39M
10-Q · filed 2026-08-13
$5.73M
derived: sum of 3 quarters · filed 2026-08-13
$70.05M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$17.70M
10-Q · filed 2026-05-14
$19.04M
derived: sum of 2 quarters · filed 2026-05-14
$83.36M
derived: sum of 3 quarters · filed 2026-05-14
$72.45M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$1.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$65.66M
derived: sum of 2 quarters · filed 2026-03-27
$54.75M
derived: sum of 3 quarters · filed 2026-03-27
$31.97M
10-K · filed 2026-03-27
2024-09-30$64.32M
10-Q · filed 2025-11-12
$53.41M
derived: sum of 2 quarters · filed 2025-11-12
$30.62M
10-Q · filed 2025-11-12
$14.71M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$10.91M
10-Q · filed 2025-08-14
-$33.70M
10-Q · filed 2025-08-14
-$49.60M
derived: sum of 3 quarters · filed 2025-08-14
-$67.35M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$22.79M
10-Q · filed 2025-05-15
-$38.69M
derived: sum of 2 quarters · filed 2025-05-15
-$56.44M
derived: sum of 3 quarters · filed 2025-05-15
-$71.05M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$15.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
-$33.65M
derived: sum of 2 quarters · filed 2025-03-24
-$48.27M
derived: sum of 3 quarters · filed 2025-03-24
-$66.27M
10-K · filed 2025-03-24
2023-09-30-$17.75M
10-Q · filed 2024-11-14
-$32.36M
derived: sum of 2 quarters · filed 2024-11-14
-$50.37M
10-Q · filed 2024-11-14
-$70.90M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$14.61M
10-Q · filed 2024-08-12
-$32.62M
10-Q · filed 2024-08-12
-$53.15M
derived: sum of 3 quarters · filed 2024-08-12
-$79.35M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$18.00M
10-Q · filed 2024-05-13
-$38.54M
derived: sum of 2 quarters · filed 2024-05-13
-$64.73M
derived: sum of 3 quarters · filed 2024-05-13
-$90.33M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$20.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$46.73M
derived: sum of 2 quarters · filed 2024-03-25
-$72.32M
derived: sum of 3 quarters · filed 2024-03-25
-$89.26M
10-K · filed 2024-03-25
2022-09-30-$26.20M
10-Q · filed 2023-11-13
-$51.79M
derived: sum of 2 quarters · filed 2023-11-13
-$68.73M
10-Q · filed 2023-11-13
-$86.02M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$25.59M
10-Q · filed 2023-08-14
-$42.53M
10-Q · filed 2023-08-14
-$59.82M
derived: sum of 3 quarters · filed 2023-08-14
-$72.11M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$16.94M
10-Q · filed 2023-05-15
-$34.23M
derived: sum of 2 quarters · filed 2023-05-15
-$46.52M
derived: sum of 3 quarters · filed 2023-05-15
-$58.06M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$17.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
-$29.58M
derived: sum of 2 quarters · filed 2023-03-14
-$41.12M
derived: sum of 3 quarters · filed 2023-03-14
-$50.63M
10-K · filed 2023-03-14
2021-09-30-$12.29M
10-Q · filed 2022-11-14
-$23.84M
derived: sum of 2 quarters · filed 2022-11-14
-$33.34M
10-Q · filed 2022-11-14
-$42.16M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$11.54M
10-Q · filed 2022-08-15
-$21.05M
10-Q · filed 2022-08-15
-$29.86M
derived: sum of 3 quarters · filed 2022-08-15
-$35.42M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$9.51M
10-Q · filed 2022-05-16
-$18.32M
derived: sum of 2 quarters · filed 2022-05-16
-$23.88M
derived: sum of 3 quarters · filed 2022-05-16
-$29.52M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$8.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06
-$14.37M
derived: sum of 2 quarters · filed 2022-04-06
-$20.02M
derived: sum of 3 quarters · filed 2022-04-06
-$34.56M
10-K · filed 2022-04-06
2020-09-30-$5.56M
10-Q · filed 2021-11-22
-$11.21M
derived: sum of 2 quarters · filed 2021-11-22
-$25.75M
10-Q · filed 2021-11-22
-$32.06M
derived: sum of 4 quarters · filed 2021-11-22
2020-06-30-$5.65M
10-Q · filed 2021-08-16
-$20.19M
10-Q · filed 2021-08-16
-$26.51M
derived: sum of 3 quarters · filed 2021-08-16
-$29.66M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$14.54M
10-Q · filed 2021-05-17
-$20.86M
derived: sum of 2 quarters · filed 2021-05-17
-$24.01M
derived: sum of 3 quarters · filed 2021-05-17
-$27.67M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$6.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$9.47M
derived: sum of 2 quarters · filed 2021-03-15
-$13.13M
derived: sum of 3 quarters · filed 2021-03-15
-$16.73M
10-K · filed 2021-03-15
-$16.73M
10-K · filed 2020-04-14
2019-09-30-$3.15M
10-Q · filed 2020-11-06
-$3.15M
10-Q · filed 2019-11-19
-$6.81M
derived: sum of 2 quarters · filed 2020-11-06
-$10.41M
10-Q · filed 2020-11-06
-$10.41M
10-Q · filed 2019-11-19
-$17.31M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$3.66M
10-Q · filed 2020-08-14
-$3.66M
10-Q · filed 2019-08-14
-$7.26M
10-Q · filed 2020-08-14
-$7.26M
10-Q · filed 2019-08-14
-$14.16M
derived: sum of 3 quarters · filed 2020-08-14
-$17.47M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$3.60M
10-Q · filed 2020-05-28
-$3.60M
10-Q · filed 2019-05-15
-$10.50M
derived: sum of 2 quarters · filed 2020-05-28
-$13.81M
derived: sum of 3 quarters · filed 2020-05-28
-$18.94M
derived: sum of 4 quarters · filed 2020-05-28
2018-12-31-$6.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14
-$10.21M
derived: sum of 2 quarters · filed 2020-04-14
-$15.34M
derived: sum of 3 quarters · filed 2020-04-14
-$18.75M
10-K · filed 2020-04-14
2018-09-30-$3.31M
10-Q · filed 2019-11-19
-$8.44M
derived: sum of 2 quarters · filed 2019-11-19
-$11.85M
10-Q · filed 2019-11-19
-$11.55M
derived: sum of 4 quarters · filed 2019-11-19
2018-06-30-$5.13M
10-Q · filed 2019-08-14
-$8.54M
10-Q · filed 2019-08-14
-$8.23M
derived: sum of 3 quarters · filed 2019-08-14
-$13.60M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$3.41M
10-Q · filed 2019-05-15
-$3.11M
derived: sum of 2 quarters · filed 2019-05-15
-$8.48M
derived: sum of 3 quarters · filed 2019-05-15
-$9.52M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$309.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$5.06M
derived: sum of 2 quarters · filed 2019-04-01
-$6.10M
derived: sum of 3 quarters · filed 2019-04-01
-$10.40M
10-K · filed 2019-04-01
2017-09-30-$5.37M
10-Q · filed 2018-11-14
-$6.41M
derived: sum of 2 quarters · filed 2018-11-14
-$10.71M
10-Q · filed 2018-11-14
-$12.42M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$1.04M
10-Q · filed 2018-08-13
-$5.34M
10-Q · filed 2018-08-13
-$7.05M
derived: sum of 3 quarters · filed 2018-08-13
-$8.98M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$4.30M
10-Q · filed 2018-05-21
-$6.01M
derived: sum of 2 quarters · filed 2018-05-21
-$7.94M
derived: sum of 3 quarters · filed 2018-05-21
-$9.25M
derived: sum of 4 quarters · filed 2018-05-21
2016-12-31-$1.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$3.64M
derived: sum of 2 quarters · filed 2018-03-14
-$4.95M
derived: sum of 3 quarters · filed 2018-03-14
-$5.65M
10-K · filed 2018-03-14
2016-09-30-$1.93M
10-Q · filed 2017-11-14
-$3.24M
derived: sum of 2 quarters · filed 2017-11-14
-$3.94M
10-Q · filed 2017-11-14
2016-06-30-$1.31M
10-Q · filed 2017-08-11
-$2.01M
10-Q · filed 2017-08-11
2016-03-31-$696.88K
10-Q · filed 2017-05-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14